A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells

PloS One
Ying LiJeffrey D Rothstein

Abstract

Amyotrophic lateral sclerosis is a progressive disease characterized by the loss of upper and lower motor neurons, leading to paralysis of voluntary muscles. About 10% of all ALS cases are familial (fALS), among which 15-20% are linked to Cu/Zn superoxide dismutase (SOD1) mutations, usually inherited in an autosomal dominant manner. To date only one FDA approved drug is available which increases survival moderately. Our understanding of ALS disease mechanisms is largely derived from rodent model studies, however due to the differences between rodents and humans, it is necessary to have humanized models for studies of disease pathogenesis as well as drug development. Therefore, we generated a comprehensive library of a total 22 of fALS patient-specific induced pluripotent stem cell (iPSC) lines. These cells were thoroughly characterized before being deposited into the library. The library of cells includes a variety of C9orf72 mutations, sod1 mutations, FUS, ANG and FIG4 mutations. Certain mutations are represented with more than one line, which allows for studies of variable genetic backgrounds. In addition, these iPSCs can be successfully differentiated to astroglia, a cell type known to play a critical role in ALS disease pro...Continue Reading

References

Aug 1, 1982·British Journal of Clinical Pharmacology·D W Vere
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
Nov 21, 2001·Nature Reviews. Neuroscience·D W Cleveland, J D Rothstein
Aug 3, 2004·Nature Reviews. Drug Discovery·Ismail Kola, John Landis
Nov 9, 2004·Developmental Biology·Ying LiuMahendra S Rao
Apr 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Han-Xiang DengTeepu Siddique
Jun 3, 2006·Science·Séverine BoilléeDon W Cleveland
Aug 23, 2006·Nature Reviews. Neuroscience·Piera Pasinelli, Robert H Brown
Oct 4, 2006·Neuron·Séverine BoilléeDon W Cleveland
Feb 16, 2007·Neurobiology of Disease·Michael Benatar
Nov 22, 2007·Science·Junying YuJames A Thomson
Feb 5, 2008·Nature Neuroscience·Koji YamanakaDon W Cleveland
Aug 12, 2008·Cell·In-Hyun ParkGeorge Q Daley
Oct 22, 2008·Nature Biotechnology·Trond AasenJuan Carlos Izpisúa Belmonte
Dec 17, 2008·Human Molecular Genetics·Ferrill F RoseChristian L Lorson
Dec 23, 2008·Nature·Allison D EbertClive N Svendsen
Feb 5, 2009·Annals of Neurology·Jeffrey D Rothstein
Mar 21, 2009·Blood·Yuin-Han LohGeorge Q Daley
Aug 22, 2009·Nature Protocols·Bao-Yang Hu, Su-Chun Zhang
Oct 20, 2009·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Noemi FusakiMamoru Hasegawa
Feb 9, 2010·Nature Methods·Fangjun JiaJoseph C Wu
Apr 10, 2010·Current Medicinal Chemistry·B C CheahM C Kiernan
Aug 5, 2010·Cell Stem Cell·Aaron M Newman, James B Cooper
Aug 5, 2011·Current Opinion in Neurobiology·Sandrine Da Cruz, Don W Cleveland

❮ Previous
Next ❯

Citations

Jan 26, 2016·International Journal of Molecular Sciences·Siddharth MenonNatalina Quarto
Mar 12, 2016·Expert Opinion on Drug Delivery·Yahya E ChoonaraViness Pillay
Jan 31, 2017·Cell Chemical Biology·Jing LiuDavid R Corey
Mar 5, 2018·Journal of Cellular and Molecular Medicine·Elena AbatiStefania Corti
Aug 9, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Olga KashpurJonathan A Garlick
Jul 21, 2017·NPJ Parkinson's Disease·Staffan HolmqvistLaurent Roybon
Jul 8, 2018·Journal of Inherited Metabolic Disease·Sabine Jung-Klawitter, Thomas Opladen
Apr 3, 2019·Nature Neuroscience·Sean J MillerJeffrey D Rothstein
Dec 22, 2019·Stem Cell Reviews and Reports·Raffaella Adami, Daniele Bottai
Aug 17, 2020·Regenerative Medicine·Juliana Ferreira VasquesFernanda Gubert
Mar 13, 2021·Advanced Therapeutics·Xiufang GuoJames J Hickman
May 9, 2021·Nature Methods·Kristopher W BrannanGene W Yeo

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
biopsies
PCR
biopsy
antisense oligonucleotide

Software Mentioned

Prism
GraphPad

Related Concepts

Related Feeds

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.

Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Astrocytes & Huntington’s Disease (MDS)

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Related Papers

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases
Loretta FerreraCecilia Garrè
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
Y BoukaftaneGuy Rouleau
© 2021 Meta ULC. All rights reserved